HIV-1 clinical isolates with the E138A substitution in reverse transcriptase show full susceptibility to emtricitabine and other nucleoside reverse transcriptase inhibitors

逆转录酶中存在E138A突变的HIV-1临床分离株对恩曲他滨和其他核苷类逆转录酶抑制剂表现出完全敏感性。